Cmed has seen accelerating demand for strategic advice and drug development consulting, both in terms of study design and CDP development, and therefore has been expanding its in-house Drug Development Consulting, Regulatory & Medical Affairs Group. Visitors to Booth #858 can take advantage of obtaining expert advice on various topics from this highly experienced team, including
Geoff Fatzinger, Vice President of Global Medical and Regulatory Affairs.
Visitors can also discover how the company’s skilled Project Managers and geographically based CRAs deliver projects to time, budget and quality, as well as hear about Cmed’s biometrics solutions for full-service trials or as a stand-alone service.
In addition, visitors will receive personal demonstrations of Cmed’s impressive e-clinical technology, Timaeus, and learn how study teams can quickly, easily and cost-effectively build and manage clinical research studies. Timaeus features new streamlined interfaces with improved query management and source data verification workflow. Investigators and Monitors are able to work
from a dynamic to-do list while Monitors quickly access study metrics from a new custom dashboard.
Cmed will also highlight how Timaeus Guided Trial Builder enables non-programmers to very rapidly build entire trials, including visit schedules, pages and edit checks. Adding Guided Trial Builder to Timaeus’ on-demand deployment capabilities enables study teams to build validated trials from a global library of standards, eliminating QC and manual hand-off delays during the study start up process.
To find out more about Cmed’s CRO services and Timaeus, visit Booth #858 at DIA 2013 Annual Meeting at the Boston Convention and Exhibition Center on June 23-27, 2013. Alternatively, visit www.cmedgroup.com for more information.